Neuralink Corporation is an American neurotechnology company founded by Elon Musk and others, developing implantable brain–machine interfaces (BMIs). The company's headquarters are in San Francisco; it was started in 2016 and was first publicly reported in March 2017.

Since its founding, the company has hired several high-profile neuroscientists from various universities. By July 2019, it had received $158 million in funding (of which $100 million was from Musk) and was employing a staff of 90 employees. At that time, Neuralink announced that it was working on a "sewing machine-like" device capable of implanting very thin threads into the brain, demonstrated a system that read information from a lab rat via 1500 electrodes (said to be 15 times more than the current maximum for systems used in human brains), and anticipated to start experiments with humans in 2020.

April 2023: reportedly looking for partners to run human trials

2022: FDA rejected application to start human trials